Benign Vulvar Disease
Transcription
Benign Vulvar Disease
Mary Lou Baxter MD FRCPC Sept 23 , 2011 Dermatology VULVOVAGINAL DISEASE Family Medicine Gynecology Lichen Sclerosus* Vulvodynia Lichen Simplex Chronicus* Lichen Planus* Psoriasis* OTHER* * May have extragenital involvement 22% 15% 7% 7% 5% 44% Lichen Sclerosus (LS) Chronic inflammatory disease Presents most frequently in postmenopausal women Mean age of onset 35-40 10-15% of cases occur in children More common in women, Caucasian population 15-20% have extragenital lesions (less symptomatic) Shoulders, back, chest Lichen Sclerosus - Appearance White, thin, fragile patches or shiny plaques +/-telangiectasiae, hemorrhage +/-erosions, ulceration +/-hyperpigmentation Bilateral, symmetrical changes Loss of normal architecture “Figure of 8”, Lichen Sclerosus - Symptoms longstanding pruritus of vulva and perianal area +/- pain, bleeding +/- dyspareunia, dysuria may be asymptomatic Lichen Sclerosus - Diagnosis History and Physical Not all loss of labia is Lichen sclerosus Doesn’t involve vagina or oral mucosa Confirmed by Biopsy Except in young and fragile Lichen Sclerosus - Etiology ?Autoimmune Thyroid disease, vitiligo Familial, genetic HLA typing Local factors (skin grafts) Lichen Sclerosus - ?Cancer 4 –5% risk of vulvar SCC in women with LS (Meffert et al. 1995) In women with vulvar SCC, 25-61% of cases have adjacent LS (Liebowitch et al. 1990) Association but ?premalignant Not clear if treatment alters risk Lichen Sclerosus - Treatment INITIAL: Topical corticosteroid Clobetasol (Dermovate®) 0.05% ointment BID x 1-2 months, then OD x 1-2 months, reassess 1-3 x per week maintenance, reassess 4-6 mos. OR taper to less potent steroid od 95 % will have complete or partial symptom relief Lichen Sclerosus - Treatment Oral antihistamines for pruritus (eg hydroxyzine 10-25 mg qid, cetirizine 10 mg qhs) Intralesional triamcinolone 3 mg/ml Barrier ointments: petrolatum, zinc oxide or silicone based (Prevex) Patient education: manage expectations vulvar skin care maintenance treatment/ followup literature Lichen Sclerosus - Treatment Testosterone/progesterone creams ineffective +/-Estrogen replacement (local/systemic) Amitriptyline (low dose) if pain is significant Vaginal dilators may be necessary (avoid surgery to correct scarring) Lichen Sclerosus Maintenance Treatment Medium or low potency topical corticosteroid ointment od or clobetasol 0.05% ung 2 – 3 x/wk Alternate: tacrolimus ointment (Protopic 0.03 -0.1%) Long term followup q 6 -12 mos Re-biopsy if suspicious for SCC LSC - Appearance Red/pink patches and plaques Lichenification Not typically symmetrical +/- hyper or hypopigmentation +/-erosions, crusts, fissures Non-scarring vulvar architecture maintained Lichen Simplex Chronicus (LSC) Also called squamous hyperplasia, hyperplastic dystrophy ?trigger factors + increased cutaneous sensory nerve activity itch scratch itch repetitive trauma, altered skin barrier and benign epidermal hyperplasia May be the end result of chronic dermatitis or any other pruritic vulvar disease LSC - Treatment Rule out other conditions Identify irritants / vulvar skin care Topical corticosteroid ointment: medium potency (eg betamethasone valerate, Prevex B) tapered to low potency (hydrocortisone 1%, Prevex HC) bid Control itch: oral antihistamines, cold, ¼% menthol added to topical corticosteroid, xylocaine 5% ointment; avoid benzocaine-containing agents LICHEN PLANUS Lichen Planus Highest incidence between age 30-60 Many mucosal and non-mucosal variants Most common is oral LP (1% all women) Of this group 50% will have genital involvement Etiology unknown ?autoimmune T-cell disorder 70% of vulvar have vaginal involvement Lichen Planus Irritating vaginal discharge and/or vulvar pain +/- intense pruritus, burning and dyspareunia May have vaginal obliteration/stenosis Rarely asymptomatic Lichen Planus Clinical Variants Papulosquamous (classic) Itchy papules and plaques with white lacy pattern on vulvar introitus Erosive (Vulvo-vaginal-gingival (VVG) syndrome) erosions/ulcers/scarring glassy red areas with white borders called Wickham’s striae Sterile yellow/green alkaline vaginal discharge Hypertrophic Least common, very itchy Often confused with LS or LSC and can look like SCC Lichen Planus - Treatment Vulvar involvement Clobetasol 0.05% ointment bid x 1 – 3 months Medium-potency topical steroid for maintenance (e.g. betamethasone valerate ointment bid) Tacrolimus 0.1% ointment bid (maintenance) Lichen Planus - Treatment Vaginal Involvement Halobetasol or Clobetasol 0.05% cream 2g intravaginally qhs (premarin applicator/tampon) Cortifoam 1 unit PV qhs (80 mg hydrocortisone) Proctotofoam (3.75 mg hydrocortisone/dose) Anusol HC suppository (10 mg) +/- intravaginal estrogen Lichen Planus - Treatment Systemic treatment rarely needed Prednisone 40 mg daily orally; taper Triamcinolone IM 1mg/kg q4weeks Intralesional triamcinolone 3 mg/ml Antimalarials, methotrexate, azathioprine, etanercept, mycophenolate mofitil Typical psoriasis; well demarcated plaque with heavy, silvery scale Vulvar Psoriasis pruritus main symptom symmetrical, well-demarcated smooth red plaques labia majora, mons fissured, red patches in intergluteal fold look for psoriasis in other sites: scalp, nails, extremities + family history Under-diagnosed Vulvar Psoriasis - Treatment Low-medium potency topical steroid ointment +/- tar (3% LCD), ¼% menthol prn itch Tacrolimus (Protopic 0.1%) ointment Calcipotriol (Dovonex) ointment Intralesional triamcinolone 3 mg/ml Oral antihistamines prn itch Responds to systemic antipsoriatic therapy if indicated (mtx, retinoids, biologics) Minimize trauma, vulvar skin care Vulvar Dermatitis Atopic Seborrheic Contact : irritant allergic Plasma Cell Vulvitis (Zoon’s) Irritant contact dermatitis to Lysol Vulvar Dermatitis pruritus +/- tenderness, dyspareunia ill-defined, red scaling patches labia majora, mons, perianal, folds +/- erosions, LSC if longstanding Vulvar Dermatitis - Treatment General measures: minimize moisture reduce overzealous washing tampons vs pads with menses replace pantiliners with incontinence pads avoid fragranced or deodorant soaps “soak & seal” Vulvar Dermatitis - Treatment medium to low potency topical steroid ointment bid barrier ointment (petrolatum, silicone, zinc oxide) prn ¼% menthol +/- oral antihistamines prn itch oral antifungal prn secondary candidiasis Zoon’s Plasma Cell Vulvitis Deep red-brown +/- petechial glistening patches Vestibule, periurethral, labia minora Burning/tenderness/dyspareunia DDx: LP/VIN 3/fixed drug eruption Path: dense band-like infiltrate/ >50% plasma cells Tx: potent topical +/intralesional corticosteroids Topical Steroid Potency Classification by steroid molecule (cream base) Weak – e.g. hydrocortisone 0.05%, 1% , hydrocortisone valerate (Hydroval) Moderately potent - e.g. betamethasone valerate (Celestoderm), mometasone (Elocom), triamcinolone(Aristocort-R) Potent – e.g. desoximetasone 0.25% (Topicort), fluocinonide (Lyderm), betamethasone diproprionate( Diprolene, Lotriderm) Very potent - e.g. clobetasol (Dermovate), halobetasol proprionate (Ultravate) Topical corticosteroids Choice of vehicle affects potency and tolerability Ointments: less likely to cause irritant or allergic contact dermatitis - more potent relative to same steroid in cream, lotion or gel base Limit amount and strength for long term use Educate patient re: correct application Striae from topical corticosteroid Secondary candidiasis Treatment: 1% hydrocortisone powder in clotrimazole cream bid +/- oral fluconazole 150 mg And if all else fails: “If it’s dry, wet it, if it’s wet, dry it, and no grease in the creases” (or ask your local Dermatologist) References Black, Martin ed. Obstetric and Gynecologic Dermatology, 3rd ed. Elsevier; 2008 Edwards, Libby and Lynch PJ, Genital Dermatology Atlas, 2nd ed. Philadelphia: Lippincott Williams & Wilkins; 2011